» Articles » PMID: 35744009

Adrenal Tumors in Young Adults: Case Reports and Literature Review

Overview
Publisher MDPI
Specialty General Medicine
Date 2022 Jun 24
PMID 35744009
Authors
Affiliations
Soon will be listed here.
Abstract

The current high detection rate of adrenal tumors (4-10% of general population) is attributable to a widespread use of variety of imaging studies, especially a computed tomography. Most of them represent clinically silent and biologically indolent incidentalomas, but some adrenal tumors may pose a significant clinical challenge. Thus, in every patient with an adrenal tumor, a decision on further management is made after careful hormonal and radiological evaluation. All hormonally active tumors and those with radiological features suggesting malignancy are qualified for surgery. Approximately 80% of adrenal tumors are adrenocortical adenomas, hypertrophy, or nodular adrenocortical hyperplasia. Other histopathological diagnoses include pheochromocytoma, adrenocortical carcinoma, metastases, mesenchymal tumors, lymphomas, cysts, and ganglioneuromas. Adrenal tumors are more commonly diagnosed and better studied in elderly patients. In younger patients, under 40 years old, focal adrenal lesions are relatively rare, and histological distribution of diagnoses differs from that in elderly individuals. Younger patients are more likely to display endocrine symptoms, which raise the suspicion of an adrenal mass. In the current study, we present a case series of seven adrenal tumors occurring in young patients. The cases presented below, along with the literature review, demonstrate that the diagnosis and treatment of adrenal tumors are crucial due to endocrinopathy-derived complications and a potential risk of malignancy.

Citing Articles

Optimization of HPLC method for metanephrine and normetanephrine detection in urine: Enhancing diagnostic precision for pheochromocytoma.

Batool H, Batool M Toxicol Rep. 2025; 14:101903.

PMID: 39897404 PMC: 11783001. DOI: 10.1016/j.toxrep.2025.101903.

References
1.
Bibi M, Sellami A, Taktak T, Chelly B, Ghorbel Z, Zouari H . Giant cystic lymphangioma of adrenal gland: A case report and review of the literature. Urol Case Rep. 2018; 22:6-7. PMC: 6171323. DOI: 10.1016/j.eucr.2018.09.022. View

2.
Ohara N, Kaneko M, Yaguchi Y, Ishiguro H, Ishizaki F, Maruyama R . A case of normotensive incidentally discovered adrenal pheochromocytoma. Clin Case Rep. 2018; 6(12):2303-2308. PMC: 6293157. DOI: 10.1002/ccr3.1772. View

3.
Cyranska-Chyrek E, Szczepanek-Parulska E, Olejarz M, Ruchala M . Malignancy Risk and Hormonal Activity of Adrenal Incidentalomas in a Large Cohort of Patients from a Single Tertiary Reference Center. Int J Environ Res Public Health. 2019; 16(10). PMC: 6571894. DOI: 10.3390/ijerph16101872. View

4.
Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E . Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol. 2014; 2(5):396-405. DOI: 10.1016/S2213-8587(13)70211-0. View

5.
Lewandowska-Graban K, Zdrojewska M, Jendrzejewski J, Sledzinski M, Peksa R, Sworczak K . A case report of melanoma metastasis to adrenal gland. Pol Arch Intern Med. 2019; 129(9):636-637. DOI: 10.20452/pamw.14896. View